Down-regulation of MSH3 and MSH6 genes in female breast cancer patients receiving taxane-based therapy
Abstract Background The DNA in each cell in our body is constantly in danger of becoming damaged. Most DNA damage gets repaired straight away via many different proteins encoded by DNA—repair genes. MSH3 and MSH6 are pivotal DNA repair genes maintaining human genome integrity. Dysregulated expressio...
Main Authors: | Hanaa R. M. Attia, Dina F. Ayoub, Shereen H. Abd El-Aziz, Mai M. Abdel Wahed, Safa N. Abd El-Fattah, Mahmoud A. Abdel-Monem, Thanaa M. Rabah, Mahmoud M. Kamel, Amany Helal, Mona Hamed Ibrahim |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-10-01
|
Series: | Future Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43094-023-00549-2 |
Similar Items
-
CYP2C8 rs11572080 and CYP3A4 rs2740574 risk genotypes in paclitaxel-treated premenopausal breast cancer patients
by: Hanaa R. M. Attia, et al.
Published: (2024-04-01) -
Taxane-induced acute interstitial pneumonitis in patients with breast cancer and outcome of taxane rechallenge
by: T M Anoop, et al.
Published: (2022-01-01) -
Cytoplasmic MSH2 Related to Genomic Deletions in the MSH2/EPCAM Genes in Colorectal Cancer Patients With Suspected Lynch Syndrome
by: Lin Dong, et al.
Published: (2021-05-01) -
Targeted Next-Generation Sequencing of MLH1, MSH2, and MSH6 Genes in Patients with Endometrial Carcinoma under 50 Years of Age
by: Taha Reşid Özdemir, et al.
Published: (2019-01-01) -
Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
by: Shirin Kianersi, et al.
Published: (2023-01-01)